Title	Publication Date	Language	Citations
A Novel Risk-based Approach Simulating Oncological Surveillance After Radical Nephroureterectomy in Patients with Upper Tract Urothelial Carcinoma	2020/12/01	English	10
Immunological Risk Stratification of Bladder Cancer Based on Peripheral Blood Natural Killer Cell Biomarkers	2021/04/01	English	10
Prevalence of Suspected Hereditary Cancer Syndromes and Germline Mutations Among a Diverse Cohort of Probands Reporting a Family History of Prostate Cancer: Toward Informing Cascade Testing for Men	2020/06/01	English	10
Unilateral or Bilateral Retroperitoneal Lymph Node Dissection in Nonseminoma Patients with Postchemotherapy Residual Tumour? Results from RETROP, a Population-based Mapping Study by the Swedish Norwegian Testicular Cancer Group	2022/04/01	English	10
Assessing the Clinical Value of Positive Multiparametric Magnetic Resonance Imaging in Young Men with a Suspicion of Prostate Cancer	2021/08/01	English	10
Long-term Outcomes for Men in a Prostate Screening Trial with an Initial Benign Prostate Biopsy: A Population-based Cohort	2019/11/01	English	10
Recommendations of Active Surveillance for Intermediate-risk Prostate Cancer: Results from a National Survey of Radiation Oncologists and Urologists	2019/03/01	English	10
Risk Assessment and Considerations for Proper Management of Elderly Men with Advanced Prostate Cancer: A Systematic Review	2020/08/01	English	10
Oncologic Surveillance After Radical Nephroureterectomy for High-risk Upper Tract Urothelial Carcinoma	2022/08/01	English	10
Phase 3 Randomized Controlled Trial of Androgen Deprivation Therapy with or Without Docetaxel in High-risk Biochemically Recurrent Prostate Cancer After Surgery (TAX3503)	2021/08/01	English	10
Treatment Facility Volume and Survival in Patients with Advanced Prostate Cancer	2020/02/01	English	10
Association between Radical Prostatectomy and Survival in Men with Clinically Node-positive Prostate Cancer	2019/09/01	English	10
Cost-effectiveness of Pembrolizumab as Second-line Therapy for the Treatment of Locally Advanced or Metastatic Urothelial Carcinoma in Sweden	2020/10/01	English	10
Incidence, Patterns, and Outcomes with Adjuvant Chemotherapy for Residual Disease After Neoadjuvant Chemotherapy in Muscle-invasive Urinary Tract Cancers	2020/10/01	English	10
Added Clinical Value of Whole-mount Histopathology of Radical Prostatectomy Specimens: A Collaborative Review	2021/08/01	English	10
Psychotherapeutic Interventions Targeting Prostate Cancer Patients: A Systematic Review of the Literature	2018/09/01	English	10
Infiltrative Renal Masses: Clinical Significance and Fidelity of Documentation	2021/04/01	English	10
Optimizing the Timing of Salvage Postprostatectomy Radiotherapy and the Use of Concurrent Hormonal Therapy for Prostate Cancer	2018/05/01	English	9
Quality of Life after Radical Prostatectomy or Watchful Waiting With or Without Androgen Deprivation Therapy: The SPCG-4 Randomized Trial	2018/06/01	English	9
How Should Molecular Markers and Magnetic Resonance Imaging Be Used in the Early Detection of Prostate Cancer?	2022/04/01	English	9
Modeling 1-year Relapse-free Survival After Neoadjuvant Chemotherapy and Radical Cystectomy in Patients with Clinical T2–4N0M0 Urothelial Bladder Carcinoma: Endpoints for Phase 2 Trials	2019/05/01	English	9
Using Grade of Recurrent Tumor to Guide Further Therapy While on Bacillus Calmette-Guerin: Low-grade Recurrences Are not Benign	2019/05/01	English	9
Where to Next for Theranostics in Prostate Cancer?	2019/03/01	English	9
A Phase 1/2 Single-arm Clinical Trial of Recombinant Bacillus Calmette-Guérin (BCG) VPM1002BC Immunotherapy in Non–muscle-invasive Bladder Cancer Recurrence After Conventional BCG Therapy: SAKK 06/14	2022/04/01	English	9
Upper Tract Urothelial Carcinoma in the Lynch Syndrome Tumour Spectrum: A Comprehensive Overview from the European Association of Urology - Young Academic Urologists and the Global Society of Rare Genitourinary Tumors	2022/02/01	English	9
Integrative Clinical and Genomic Characterization of MTAP-deficient Metastatic Urothelial Cancer	2023/04/01	English	9
Immune Checkpoint Inhibitors in Front-line Therapy for Urothelial Cancer	2021/12/01	English	9
Does Variant Histology Change Management of Non-muscle-invasive Bladder Cancer?	2021/06/01	English	9
Nationwide Patterns of Care for Stage II Nonseminomatous Germ Cell Tumor of the Testicle	2020/04/01	English	9
En Bloc Versus Conventional Resection of Primary Bladder Tumor (eBLOC): A Prospective, Multicenter, Open-label, Phase 3 Randomized Controlled Trial	2023/10/01	English	9